Alzheimer’s Drugs


Alzheimer’s Disease Trial Doses First Patient

Amylyx Pharmaceuticals, Inc. in collaboration with the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation (ADDF) and the Cure Alzheimer’s Fund announced the dosing of its first patients in a recently expanded Phase II clinical trial. The trial, known...

Pin It on Pinterest